tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market

Akari Therapeutics (AKTX) Technical Analysis

Compare
285 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Akari Therapeutics’s (AKTX) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Akari Therapeutics is a Buy.
Akari Therapeutics’s (AKTX) 20-Day exponential moving average is 1.19, while Akari Therapeutics’s (AKTX) share price is $1.1, making it a Sell.
Akari Therapeutics’s (AKTX) 50-Day exponential moving average is 1.19, while Akari Therapeutics’s (AKTX) share price is $1.1, making it a Sell.

Akari Therapeutics (AKTX) Pivot Points

Apr 03, 2025, 02:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.20
1.22
1.23
1.25
1.26
1.28
1.29
Fibonacci
1.22
1.23
1.24
1.25
1.26
1.27
1.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akari Therapeutics (AKTX) Moving Averages

Apr 03, 2025, 02:46 PM
Period
Simple
Exponential
MA5
1.20Sell
1.19Sell
MA10
1.33Sell
1.22Sell
MA20
1.17Sell
1.19Sell
MA50
1.13Sell
1.19Sell
MA100
1.25Sell
1.39Sell
MA200
2.23Sell
1.87Sell
Akari Therapeutics’s (AKTX) 10-Day exponential moving average is 1.22, while Akari Therapeutics’s (AKTX) share price is $1.1, making it a Sell.
Akari Therapeutics’s (AKTX) 100-Day exponential moving average is 1.39, while Akari Therapeutics’s (AKTX) share price is $1.1, making it a Sell.
Akari Therapeutics’s (AKTX) stock price is $1.1 and Akari Therapeutics’s (AKTX) 50-day simple moving average is 1.13, creating a Sell signal.
Akari Therapeutics’s (AKTX) stock price is $1.1 and Akari Therapeutics’s (AKTX) 100-day simple moving average is 1.25, creating a Sell signal.
Akari Therapeutics’s (AKTX) stock price is $1.1 and Akari Therapeutics’s (AKTX) 200-day simple moving average is 2.23, creating a Sell signal.

Akari Therapeutics (AKTX) Technical Indicators

Apr 03, 2025, 02:46 PM
Name
Value
Implied Action
RSI (14)
45.23
Neutral
STOCH (9,6)
7.78
Buy
STOCHRSI (14)
36.79
Neutral
MACD (12,26)
0.06
Buy
ADX (14)
31.45
Neutral
Williams %R
-76.55
Buy
CCI (14)
-3.20
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
29.34
Sell
ROC
20.88
Buy
Akari Therapeutics’s (AKTX) Relative Strength Index (RSI) is 45.23, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Trend Strength Indicator (ADX) is 31.45, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Commodity Channel Index (CCI) is -3.20, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Price Rate of Change (ROC) is 20.88, creating a Buy signal.

FAQ

Is AKTX a Buy, Hold, or Sell?
Based on AKTX’s technical indicators, AKTX is a Strong Sell.
    What is AKTX’s RSI (14)?
    AKTX’s RSI (14) is 45.23, which suggests AKTX is a Neutral.
      What is AKTX’s MACD?
      AKTX’s MACD is 0.06, which suggests AKTX is a Buy.
        What is AKTX’s 5-day moving average?
        AKTX’s 5-day moving average is 1.20, which suggests AKTX is a Sell.
          What is AKTX’s 20-day moving average?
          AKTX 20-day moving average is 1.17, which suggests AKTX is a Sell.
            What is AKTX’s 50-day moving average?
            AKTX’s 50-day moving average is 1.13, which suggests AKTX is a Sell.
              What is AKTX’s 200-day moving average?
              AKTX’s 200-day moving average is 2.23, which suggests AKTX is a Sell.
                What is AKTX’s Williams % R (14)?
                AKTX’s Williams % R (14) is -76.55, which suggests AKTX is a Buy.
                  What is AKTX’s CCI (14)?
                  AKTX’s CCI (14) is -3.20, which suggests AKTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis